2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$23.93-$0.06 (-0.25%)
Price as of Sep 11, 2026 7:30 PM EDT- $783.1MMarket Cap
- 289.45%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$23.93-$0.06 (-0.25%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.99 | ||
Change | +$1.50 (+6.67%) | ||
Open | $22.96 | ||
High | $24.24 | ||
Low | $22.28 | ||
Previous Close | $22.49 | ||
Volume | 221,084 | ||
30-Day Average Volume | 191,306 | ||
1-Week Change | -2.04% | ||
1-Month Change | 23.60% | ||
1-Year Change | 289.45% | ||
3-Year Change | 74.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 32.6M | ||
Total Assets | $22.4M | ||
Market Cap | $783.1M | ||
Enterprise Value | $761.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$4.5M | ||
EBIT | -$7.0M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $9.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -108 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 86 | ||
P/E | -80 | ||
PEG | 5 | ||
Price/Free Cash Flow | -173 | ||
Price/Operating Cash Flow | -173 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue